Biosimilar Drug ABP 980 was Found Effective

Sean Harper, Amgen’s executive vice president of research and development said ABP 980 was found as effective Roche’s Herceptin (used to treat a type of early breast cancer) in a late-stage study. Read article here….

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or